Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Levocarnitine Injections on Reducing Erythropoietin-Stimulating Agent Requirements in Hemodialysis Patients With Renal Anemia

NCT07160452 is registered in ClinicalTrials.gov with Shaikh Zayed Hospital, Lahore as lead sponsor.

NCT NCT07160452
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07160452 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Levocarnitine Injections on Reducing Erythropoietin-Stimulating Agent Requirements in Hemodialysis Patients With Renal Anemia
Lead sponsor
Shaikh Zayed Hospital, Lahore
Phase
Phase 4
Overall status
Not yet recruiting
Start date
September 15, 2025
Completion date
March 15, 2026
Enrollment
94 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

anemia, end-stage renal disease, kidney failure, renal dialysis